Biotech Capital Research 
Alpha Sense BI
MAY 28, 2024
The venture capital landscape continues to test the discipline and diligence of investors and startups alike. Like many other asset classes, venture capital continues to be impacted by lingering macroeconomic factors affecting funding and liquidity prospects. Interest rates are high.
Alpha Sense BI
FEBRUARY 8, 2023
Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices — as well as their intentions to scale their digital health solutions — to the masses in hopes of securing capital.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Alpha Sense BI
APRIL 29, 2024
Heading into the second half of 2024, venture capital investors remain cautious as they acknowledge persistent challenging dynamics in the landscape. While dry powder reserves have reached record highs, investors are wary about deploying capital with certain recent macroeconomic factors still fresh in mind.
Alpha Sense BI
JANUARY 25, 2023
Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.
Owler
JUNE 14, 2023
The funding round was led by venture capital firm Andreessen Horowitz. in Funding Founded in 2014, venture capital firm Swanlaab Venture Factory says it, “aims to invest in early-stage Spanish startups with B2B business models and clear technological differentiation.” Swanlaab Venture Factory Receives $48.1M
Alpha Sense BI
JANUARY 26, 2024
Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.
Alpha Sense BI
APRIL 19, 2024
On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. According to broker research on the AlphaSense platform, Apple’s release of Vision Pro is a pivotal moment that marks the advent of spatial computing and could transform how people see and interact with technology.
Expert insights. Personalized for you.
69 
Let's personalize your content